Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies
- 1 October 2000
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 43 (2) , 171-196
- https://doi.org/10.1053/pcad.2000.7010
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: A multicenter parallel group studyAmerican Heart Journal, 1999
- Safety of Nifedipine in Angina PectorisHypertension, 1999
- Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE study experienceAmerican Heart Journal, 1998
- Cancer Risk in Users of Calcium Channel BlockersHypertension, 1997
- Effect of Calcium Channel or β-Blockade on the Progression of Diabetic Nephropathy in African AmericansHypertension, 1997
- A comparison of the acute hypotensive effects of two different doses of nifedipineAmerican Heart Journal, 1992
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1986
- Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.Circulation, 1984
- Verapamil for unstable angina at rest: A short-term randomized, double-blind studyAmerican Heart Journal, 1983